Publications by authors named "Pooi S Lee"

13Publications

Minocycline treatment for pulmonary Mycobacterium avium complex disease based on pharmacokinetics/pharmacodynamics and Bayesian framework mathematical models.

J Antimicrob Chemother 2019 07;74(7):1952-1961

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkz143DOI Listing
July 2019

Once-a-week tigecycline for the treatment of drug-resistant TB.

J Antimicrob Chemother 2019 06;74(6):1607-1617

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkz061DOI Listing
June 2019

The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.

Clin Infect Dis 2018 11;67(suppl_3):S336-S341

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://fdslive.oup.com/www.oup.com/pdf/production_in_progres
Publisher Site
http://dx.doi.org/10.1093/cid/ciy626DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260152PMC
November 2018

Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.

Clin Infect Dis 2018 11;67(suppl_3):S317-S326

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260165PMC
November 2018

Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.

Clin Infect Dis 2018 11;67(suppl_3):S342-S348

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260150PMC
November 2018

Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.

Antimicrob Agents Chemother 2018 02 25;62(2). Epub 2018 Jan 25.

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas, USA

View Article

Download full-text PDF

Source
http://aac.asm.org/lookup/doi/10.1128/AAC.02232-17
Publisher Site
http://dx.doi.org/10.1128/AAC.02232-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786797PMC
February 2018

A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.

J Antimicrob Chemother 2017 Sep;72(suppl_2):i48-i53

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://academic.oup.com/jac/article/72/suppl_2/i48/4110806/A
Publisher Site
http://dx.doi.org/10.1093/jac/dkx307DOI Listing
September 2017

The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.

J Antimicrob Chemother 2017 Sep;72(suppl_2):i36-i42

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkx306DOI Listing
September 2017

Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.

J Antimicrob Chemother 2017 Sep;72(suppl_2):i30-i35

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://academic.oup.com/jac/article/72/suppl_2/i30/4110804/T
Publisher Site
http://dx.doi.org/10.1093/jac/dkx305DOI Listing
September 2017

Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis.

Sci Adv 2017 08 30;3(8):e1701102. Epub 2017 Aug 30.

Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX 75204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciadv.1701102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576880PMC
August 2017